Sertraline and Hypokalemia Risk
Sertraline is not likely to cause hypokalemia and is not recognized as a cause of this electrolyte disturbance in clinical practice. The FDA drug label for sertraline does not list hypokalemia as an adverse effect, and the medication is actually associated with hyponatremia (low sodium), not hypokalemia 1.
Evidence from FDA Labeling
The official FDA prescribing information for sertraline specifically warns about hyponatremia as a known adverse effect, particularly in elderly patients and those taking diuretics 1. The drug label makes no mention of hypokalemia as an adverse event associated with sertraline use 1.
Clinical Research Findings
Systematic Laboratory Monitoring Study
A comprehensive study of 246 patients treated with sertraline examined routine blood chemistry values before and after treatment 2. This study found no significant changes in serum potassium levels with sertraline therapy, and identified no relationship between sertraline dose, patient age, and changes in potassium levels 2.
Isolated Case Report
There is only one documented case report in the medical literature of severe hypokalemia potentially associated with sertraline use 3. This 2014 case involved a 48-year-old male who developed ventricular fibrillation with a potassium level of 2.44 mEq/L while taking sertraline 50 mg daily 3. However, even in this single case, the authors noted there was "no clear pathogenic mechanism" for how sertraline could affect potassium levels, and the Naranjo scale indicated only a "probable" (not definite) relationship 3.
Pharmacovigilance Data
A large pharmacovigilance study examining QT prolongation with SSRIs found no signal for hypokalemia with sertraline 4. When hypokalemia was present in cases involving SSRIs, it was typically associated with other medications or conditions, not the antidepressant itself 4.
Clinical Context: Actual Electrolyte Concerns
The primary electrolyte disturbance to monitor with sertraline is hyponatremia, not hypokalemia 1. The FDA label specifically warns that:
- Hyponatremia may occur through SIADH (syndrome of inappropriate antidiuretic hormone secretion) 1
- Elderly patients are at greater risk 1
- Patients taking diuretics or who are volume depleted have increased risk 1
- Cases with sodium levels below 110 mmol/L have been reported 1
Practical Implications
When prescribing sertraline:
- Monitor sodium levels, particularly in elderly patients and those on diuretics 1
- Routine potassium monitoring is not indicated based on sertraline use alone 2
- If hypokalemia develops in a patient on sertraline, investigate other causes such as diuretic use, gastrointestinal losses, or other medications 3
- The combination of sertraline with diuretics warrants monitoring for hyponatremia, not hypokalemia 1
In summary, hypokalemia is not a recognized adverse effect of sertraline based on FDA labeling, systematic research, and clinical experience. The single case report in the literature represents an extremely rare occurrence without established causality 3.